Filing Details

Accession Number:
0001209191-14-076623
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-18 16:02:52
Reporting Period:
2014-12-15
Filing Date:
2014-12-18
Accepted Time:
2014-12-18 16:02:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1517022 Akebia Therapeutics Inc. AKBA Pharmaceutical Preparations (2834) 208756903
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591467 P. John Butler C/o Akebia Therapeutics, Inc.
245 First Street, Suite 1100
Cambridge MA 02142
Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-15 1,000 $11.34 46,350 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2014.